Impact of PET-FDG in the diagnosis and therapeutic care of patients presenting with metastases of unknown primary

Cancer Investigation

Volumn 25, Issue 4, 2007, Pages 232-239

  Garin, Etienne ^a   Prigent Lejeune, Florence ^a   Lesimple, Thierry ^a   Barge, Marie Luce ^a   Rousseau, Caroline ^b   Devillers, Anne ^a   Bouriel, Catherine ^a   Habiba, Mesbah T ^a   Bernard, Anne Marie ^a   Bridji, Boumédienne ^b   Resche, Isabelle ^b  

^a CENTRE EUGÈNE MARQUIS   (France)

^b CENTRE RENÉ GAUDUCHEAU   (France)

Author keywords

Carcinoma of unknown origin; PET FDG; Primary; Therapeutic impact

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; PATIENT CARE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

DNA-BINDING PROTEINS; FLUORODEOXYGLUCOSE F18; HUMANS; NEOPLASMS, UNKNOWN PRIMARY; POSITRON-EMISSION TOMOGRAPHY; RADIOGRAPHY, THORACIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34347387739     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900701206331     Document Type: Article

References (30)

1. Abbruzzese, J.L.; Abbruzzese, M.C.; Hess, K.R.; Raber, M.N.; Lenzi, R.; Frost, P. Unknown primary carcinoma: natural history and pronostic factors in 657 consecutive patients. J. Clin. Oncol. 1994, 12, 1272-1280.
2. Abbruzzese, J.L.; Abbruzzese, M.C.; Lenzi, R.; Hess, K.R.; Raber, M.N. Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin. J. Clin. Oncol. 1995, 13, 2094-2103.
3. Daugaard, G. Unknown primary tumors. Cancer Treat. Rev. 1994, 20 (2), 119-147.
4. Nystrom, J.; Wienner, J.; Wolph, R.; Bateman, J.; Viola, M. Identifying the primary site in metastatic cancer of unknown origin: inadequacy of roentgraphyc procedures. JAMA 1979, 241, 381-383.
5. Wang, R.C.; Goepfert, H.; Barber, A.E.; Wolf, P. Unknown primary squamous cell carcinoma metastatic to the neck. Arch. Otolaryngol. Head Neck Surg. 1990, 116, 1388-1393.
6. Hiibner, G.; Wildfang, I.; Schmoll, H.J. CUP. In: Schmoll, H.J. (ed.): Kompendium Internistische Onkologie Band 2. Berlin-Heidelberg-New York: Springer 1999; 2137-2182.
7. Greven, K.M.; Keyes, J.W.; William, T.J.; McGuirt, W.F.; Joyce, W.T. Occult primary tumors of the head and neck. Lack of benefit from positron emission tomography inmaging with 2- (F-18)fluoro-2-deoxy-D-glucose. Cancer 1999, 86, 114-118.
8. Gupta, N.C.; Nicholson, P.; Bloomfield, S.M. FDG-PET in the staging work-up of patients with suspected intracranial metastatic tumors. Ann. Surg. 1999, 230 (2), 202-206.
9. Bohuslavizki, K.H.; Klutmann, S.; Kroger, S.; Sonnemann, U.; Buchert, R.; et al. FDG PET detectionof unknown primary tumors. J. Nucl. Med. 2000, 41, 816-822.
10. Regelink, G.; Brouwer, J.; de Bree, R.; Pruim, J.; van der Lan, B.F.A.M.; et al. Detection of unknown primary tumors and distant metastases in patients with cervical metastases: value of FDGPET versus conventional modalities. Eur. J. Nucl. Med. 2002, 29, 1024-1030.
11. Gutzeit, A.; Antoch, G.; Kuhl, H.; Egelhof, T.; et al. Unknown primary tumors: detection with dual-modality PET/CT-initial experience. Radiology 2005; 234(1), 227-34.
12. Kole, A.C.; Nieweg, O.E.; Pruim, J.; Hoekstra, H.J.; Koops, H.S.; et al. Detection of unknown primary tumors using positron emission tomography. Cancer 1998, 82, 1160-1166.
13. Rades, D.; Kiilnel, G.; Wildfang, I.; Borner, A.R.; Schmoll, H.J.; Knapp, W. Localised disease in cancer of unknown primary (CUP): the value of positron emission tomography (PET) for individual therapeutic management. Ann. Oncol. 2001, 12, 1605-1609.
14. Rege, S.; Maass, A.; Chaiken, L.; Hoh, C.K.; Choi, Y.; et al. Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancer. Cancer 1994, 73, 3047-3058.
15. Mukherji, S.K.; Drane, W.E.; Mancuso, A.A.; Parsons, J.T.; Mendenhall, W.M.; Stringer, S. Occult primary tumors of the head and neck: detection with 2-(F-18)fluoro-2-deoxy-D-glucose SPECT. Radiology 1996, 199, 761-766.
16. Braams, J.W.; Pruim, J.; Kole, A.C.; Nikkels, P.G.J.; Vaalburg, W.; et al. Detection of unknown primary head and neck tumors by positron emission tomography. Int. J. Oral. Maxillofac. Surg. 1997, 26, 112-115.
17. Hanasono, M.M.; Kunda, L.D.; Segall, G.M.; Ku, G.H.; Terris, D.J. Uses and limitations of FDG positron emission tomography in patients with head and neck cancer. Laryngoscope 1999, 109, 880-885.
18. Aassar, O.S.; Fischbein, N.J.; Caputo, G.R.; Kaplan, M.J.; Price, D.C.; et al. Metastatic head and neck cancer : role and usefulness of FDG PET in locating occult primary tumors. Radiology 1999, 210, 177-181.
19. Stokkel, M.P.M.; Terhaard, C.H.; Hordijk, G.J.; van Rijk, P.P. The detection of unknown primary tumors in patients with cervical metastases by dual-head positron emission tomography. Oral Oncology 1999, 35, 390-394.
20. Safa, A.A.; Tran, L.M.; Rege, S.; Brown, C.V.; Mandelkern, M.A.; et al. The role of positron emission tomography in occult primary head and neck cancers. Cancer J. Sci. Am. 1999, 5, 214-218.
21. Jungehulsing, M.; Scheidhauer, K.; Damm, M.; Pietrzyk, U.; Ekel, H.; et al. 2(18F)-fluoro-2-deoxy-D-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation. Otolaryngol. Head Neck. Surg. 2000, 123, 294-301.
22. Johansen, J.; Eigtved, A.; Buchwald, C.; Theilgaard, S.A.; Hansen, H.S. Implication of 18F- fluoro-2-deoxy-D-glucose positron emission tomography on management of carcinoma of unknown primary in the head and neck: a Danish cohort study. Laryngoscope 2002, 112, 2009-2014.
23. Wong, W.L.; Saunders, M. The impact of FDG PET on the management of primary of occult primary head and neck tumors. Clin. Oncol. (R. Coll. Radiol.) 2003, 15 (8), 461-466.
24. Stoeckli, S.J.; Mosna-Firlejczk, K., Goerres, G.W. Lymph node metastasis of squamous cell carcinoma from an unknown pprimary: impact of positron emission tomography. Eur. J. Nucl. Med. 2003, 30, 441-416.
25. Freudenberg, L.S.; Fischer, M.; Antoch, G.; Jentzen, W.; Gutzeit, A.; et al. Dual modality of 18F-fluorodeoxyglucose positron emission tomography in patients with cervical carcinoma of unknown primary. Med. Princ. Pract. 2005, 14, 155-160.
26. Lassen, U.; Daugaard, G.; Eigtved, A.; Damgaard, K.; Friberg, L. 18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumors (UPT). Eur. J. Cancer 1999, 35 (7), 1076-1082.
27. Lonneux, M.; Reffad, A.M. Metastases from unknown primary tumor: PET-FDG as initial staging procedure. Clin. Positron Imaging 2000, 3 (4), 137-141.
28. Alberini, J.L.; Belhocine, T.; Hustinx, R.; Daenen, F.; Rigo, P. Wholebody positron emission tomography using fluorodeoxyglucose in patients with metastases of unknown primary tumors (CUP syndrome). Nucl. Med. Comm. 2003, 24, 1081-1086.
29. Mantaka, P.; Baum, R.P.; Hertel, A.; Adams, S.; Nissen, A.; et al. PET with 2- (F-18)6fluoro-2-Deoxy-D-glucose (FDG) in patients with cancer of unknown primary (CUP): influence on patients'diagnostic and therapeutic management. Cancer Biother Radiopharm. 2003, 18, 47-58.
30. Nanni, C.; Rubello, D.; Castelluci, P.; Farsad, M.; Franchi, R.; Toso, S.; Barile, C.; Rampin, L.; Nibale, O.; Fanti, S.; Role of 18 F-FDG PET-CT imaging for the detection of an unknown primary tumour: preliminary results of 21 patients. Eur. J. Nucl. Med. Mol. Imaging 2005, 32, 589-592.